Table 4.
Odds ratio and confidence intervals for predictors of residual symptoms, reduced FVC, abnormal CXR, and CT findings
| Residual Symptoms | Reduced FVC | Abnormal CXR | Abnormal CT | |
|---|---|---|---|---|
| Age |
0.95** [0.91, 0.99] |
1.03 [0.99, 1.07] |
1.11** [1.05, 1.18] |
1.11** [1.04, 1.18] |
| Gender (male) |
1.62 [0.54. 4.84] |
1.08 [0.35, 3.31] |
6.12* [1.36, 27.57] |
2.52 [0.58, 10.92] |
| Any medical history |
3.08 [0.93, 10.20] |
1.24 [0.35, 4.33] |
0.63 [0.14, 2.72] |
0.53 [0.12, 2.35] |
| Cancer |
2.52 [0.40, 15.76] |
1.29 [0.22, 7.46] |
1.23 [0.14, 11.19] |
0.13 [0.01, 2.56] |
| Smoker/past smoker |
0.20* [0.04, 0.95] |
1.37 [0.35, 5.41] |
1.17 [0.15, 9.32] |
0.62 [0.10, 4.01] |
| Cough on presentation |
0.26 [0.06, 1.12] |
0.67 [0.18, 2.45] |
0.63 [0.10, 3.89] |
3.98 [0.62, 25.69] |
| Dyspnea on presentation |
0.60 [0.18, 2.05] |
2.74 [0.77, 9.67] |
8.93** [1.71, 46.58] |
3.80 [0.46, 31.49] |
| Fatigue on presentation |
0.74 [0.11, 5.09] |
1.29 [0.25, 6.70] |
1.89 [0.26, 13.72] |
3.40 [0.30, 38.40] |
| SaO2 on presentation |
1.16* [1.03, 1.31] |
0.91 [0.81, 1.03] |
0.93 [0.78, 1.11] |
0.93 [0.83, 1.05] |
| Respiratory support |
0.58 [0.08, 4.11] |
1.19 [0.12, 11.66] |
4.03 [0.28, 58.47] |
2.33 [0.11, 48.09] |
| Antibiotics treatment |
2.33 [0.61, 8.95] |
0.20 [0.03, 1.18] |
2.74 [0.59, 12.82] |
2.11 [0.50, 8.93] |
| Remdesivir treatment |
6.56* [1.21, 35.51] |
0.39 [0.06, 2.33] |
2.94 [0.39, 22.38] |
0.81 [0.11, 6.27] |
| Dexamethasone treatment |
0.45 [0.05, 4.40] |
3.37 [0.25, 53.77] |
0.18 [0.01, 5.39] |
0.04 [0.00, 1.12] |
| Anticoagulation treatment |
7.43* [1.01, 54.47] |
0.13 [0.01, 1.33] |
1.02 0.08, 13.33] |
10.02 [0.84, 119.12] |
SaO2 oxygen saturation on room air
*p < 0.05